Scheiermann N, Kuwert E K
Med Klin. 1979 May 25;74(21):820-4.
A study was undertaken to assess the viral antibody spectrum in human immunoglobulin preparations from four different manufacturers for intravenous and/or intramuscular application. Studies of the kind seem to be reasonable for calculating the expected therapeutic effect of the administered immunoglobulin. The investigated 16 gammaglobulin batches showed almost the same variety of viral antibodies and only slightly differring antibody titers. It is interesting to note, that antibodies to vaccinia virus could not be demonstrated. Quantitative determination of viral antibody titers in immunoglobulin preparations for standardization purposes should include the testing of antibodies to viruses against which a therapy with gammaglobulins is reasonable.
开展了一项研究,以评估来自四家不同制造商的用于静脉内和/或肌肉内注射的人免疫球蛋白制剂中的病毒抗体谱。此类研究对于计算所施用免疫球蛋白的预期治疗效果似乎是合理的。所研究的16批丙种球蛋白显示出几乎相同的病毒抗体种类,且抗体效价仅有轻微差异。值得注意的是,未检测到抗痘苗病毒抗体。为标准化目的对免疫球蛋白制剂中的病毒抗体效价进行定量测定时,应包括检测针对用丙种球蛋白进行治疗合理的病毒的抗体。